2nd Quarter - Report

AMERICAN CLINICAL LABORATORY ASSN for AMERICAN CLINICAL LABORATORY ASSN

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$690,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 19, 2024 $690,000 Replaced
2nd Quarter - Amendment Nov 8, 2024 $575,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; FY 2024 budget and appropriations processes, extension of telehealth coverage policies, ordering of laboratory services pursuant to a telehealth visit, artificial intelligence in laboratory services; public-private sector testing response to Influenza A (H5) avian flu; H.R. 2377/S. 1000, Saving Access to Laboratory Services Act; H.R. 8818, American Privacy Rights Act of 2024; H.R. 8702/S. 4532, Improving Seniors Timely Access to Care Act; H.R. 7623, Telehealth Modernization Act of 2024; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; H.R. 2369 the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2023.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ —
SUSAN VAN METER —
MARY LEE WATTS New —

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 2377 (118th), H.R. 8261 (118th), H.R. 8702 (118th), H.R. 7623 (118th), H.R. 2369 (118th), S. 1000 (118th), S. 4532 (118th), H.R. 8818 (118th)

Medicare/Medicaid MMM

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); Saving Access to Laboratory Services Act H.R. 2377/S. 1000; H.R. 8702/S. 4532, Improving Seniors Timely Access to Care Act.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ —
SUSAN VAN METER —
MARY LEE WATTS New —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 4532 (118th), H.R. 8702 (118th), H.R. 2377 (118th), S. 1000 (118th)

Health Issues HCR

Reimbursement and coverage issues for and related to clinical laboratory services, including the Medicare clinical laboratory fee schedule, test coding and pricing, coverage, and payment, and implementation of the Protecting Access to Medicare Act (P.L. 113-93); FDA and CMS policies related to diagnostics and laboratory regulation; price transparency for clinical laboratory services; H.R. 2377/S. 1000, Saving Access to Laboratory Services Act; H.R. 8818, American Privacy Rights Act of 2024; Improving Seniors Timely Access to Care Act; H.R. 7623, Telehealth Modernization Act of 2024; H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act; H.R. 2369 the Verifying Accurate Leading-edge IVCT Development Act (VALID Act) of 2023.

LobbyistCovered position, as disclosed
HOLLY GROSHOLZ —
SUSAN VAN METER —
MARY LEE WATTS New —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1000 (118th), H.R. 2369 (118th), H.R. 8261 (118th), H.R. 7623 (118th), H.R. 8818 (118th), H.R. 2377 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.